Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Annual Overview of the Chinese Pharmaceutical Sector 2019 and Outlook for 2020 -... Chief Editor James Shen offers his Annual Review of the Chinese Pharmaceutical Sector 2019 and Outlook for 2020, which provides an comprehensive overview of all important... (2/3/2020) U.S.-China Trade Deal Shows Potential for Improved U.S. Intellectual Property Rights in China (2/14/2020) FT: Sanofi Turns to AI to Cut Chinese Recruitment Churn (2/12/2020) Drugmakers Braced for Coronavirus Disruption to China Supplies (2/11/2020) China's Move to Patent Gilead's Experimental Drug for The Novel Virus Could Lead to Legal Wrangle (2/6/2020) China's Drug Patent Grab Makes Coronavirus Scary for Pharma (2/6/2020) Annual Overview of the Chinese Pharmaceutical Sector 2019 and Outlook for 2020 - Chinese Pharma Remain Trapped in Cloud as Industry Recalibrates (2/3/2020) Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2019 (2/3/2020) China Launches Price War to Reshuffle Pharma Industry; Bayer Cuts Prices By 90% To Secure Market (2/2/2020) Can AliHealth Transform China's Pharma Industry? (2/2/2020) Trade Deal Could Help China's Biotech Upgrade, If Honored (2/2/2020) US-China Trade Agreement - Pharma Impacts (1/23/2020) AZ Boss Claims Coronavirus 'Very Contained', as China Locks Down Wuhan to Control Spread (1/22/2020) (free) Celebrity Doctor Pay Exposes China's Healthcare Gap (1/22/2020) Impact of the China-U.S. Trade Deal on Intellectual Property Protection (1/22/2020) BeiGene: The Poster Child Of China's Booming Biopharma Market (1/22/2020) Recent Executive Moves  (2/21/2020) WHO: Early Trial Results for Coronavirus...  (2/21/2020) (free) Chinese Foundation Grants $2.1M to Colum...  (2/21/2020) Wuxi AppTec Eyes U.S. Expansion amid Chi...  (2/20/2020) Jinghua Pharma Drops Development of Two ...  (2/20/2020) Vifor Pharma and Fresenius Kabi Create J...  (2/20/2020) Pharma and MedTech Outlook Clouded by Co...  (2/20/2020) Teva Pharm Eyes Launch of Huntington's D...  (2/20/2020) U.S. FDA Suspends China Inspections, War...  (2/20/2020) Terns Pharma Announces Positive Results ...  (2/19/2020) Gilead Struggles to Recruit Patients for...  (2/19/2020) Sanofi to Partner with BARDA for Coronav...  (2/19/2020) NHSA Releases Draft Interim Regulations ...  (2/19/2020) China to Fast-Track Biosecurity Law in W...  (2/17/2020) WuXi AppTec to Invest over $30M in CANbr...  (2/17/2020) Pfizer to Absorb Mylan, Creating Global Generic Powerhou... PhRMA Calls for Trade Deals That Force Countries to Pay ... IQVIA: Global Pharma to Grow Slower in the Next Five Yea... Pfizer and GSK Announce JV to Create a Global Consumer H... Top 25 Global Pharmaceutical Companies by Market Cap 201... China Prostate Cancer Diagnostic and Therapeutic Market Analysi... GlobalData: NRDL Updates Could Lead to Increased Access to Inno... PHIIC: Data Snapshots of Chinese Pharma Market 2013-2019E Chinese Cancer Drug Market to Surpass $30+ Billion by 2025 NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018 Wuxi AppTec Eyes U.S. Expansion amid Chinese Facilities Disr... Jinghua Pharma Drops Development of Two mAbs Licensed from K... Vifor Pharma and Fresenius Kabi Create JV in China for IV Ir... Pharma and MedTech Outlook Clouded by Coronavirus Outbreak Teva Pharm Eyes Launch of Huntington's Drug in China This ye... U.S. FDA Suspends China Inspections, Warns of Potential ... WHO Posts New Procedure for Using Unapproved Drugs in He... NMPA Announces Implementation of Four Series Q ICH Guide... NMPA Publicizes List of Reference Formulations for Gener... Review of Chinese Drug Registration Applications and App... China to Fast-Track Biosecurity Law in Wake of Coronavirus CNIPA Releases the 2019 Statistics on Patent, Trademark, GI ... Pfizer Sues to Block Copies of Smoking-Cessation Pill Chanti... Wuhan Institute of Virology Applies for Use Patent for Gilea... U.S.-China Phase 1 Deal Hands Pharma MNCs A Major IPR Win India May Soon Impose Temporary Export Ban on Numerous E... U.S. Senior Official Urges to Reduce Dependence on Chine... Coronavirus Outbreak to Disrupt Supplies of Drug Ingredi... Coronavirus Threatens Global API Sourcing from China Coronavirus A Growing Threat To Global Supply Chains - P... WHO: Early Trial Results for Coronavirus Treatments Expe... Chinese Foundation Grants $2.1M to Columbia Researchers ... Terns Pharma Announces Positive Results of Phase 1 Trial... Gilead Struggles to Recruit Patients for Coronavirus Dru... Sanofi to Partner with BARDA for Coronavirus Vaccine Dev... NHSA Releases Draft Interim Regulations for Designated M... National Primary Healthcare Working Conference Highlight... National Drug Registration and Post-marketing Surveillan... Round 2 of the National Level Centralized Drug Purchase ... Chinese Birthrate Falls To Lowest Level In 70 Years Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Hengrui's Billionaire Founder Retires into the Backseat U.S. and China Inks Phase One Trade Deal Amid Trade War, China Lowers Import Tariffs on 850 Produ... Upcoming Event: International Conference on Biosimilars ... Upcoming Event: Biologics Manufacturing Asia 2020 Upcoming Event: Asia Wellness Expo 2020 Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Publishes the China Phar...   WiCON to Hold Pharma China Ann...   WiCON Publishes the China Phar...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links